Optimizing dose enhancement with Ta2O5 nanoparticles for synchrotron microbeam activated radiation therapy
Cancer remains one of the leading causes of death worldwide. Amongst other treatment methods, such as surgery and chemotherapy, the use of radiation in the treatment of cancer remains the most prominent and successful modality [1]. The sensitive treatment of brain tumours (such as inoperable gliomas), with wide, and unsegmented radiotherapeutic beams, impart unavoidable yet clinically unacceptable damage to vital central nervous system (CNS) tissues [2,3]. Microbeam radiation therapy (MRT) may provide a solution to achieve tumour control and normal tissue sparing.
Source: Physica Medica: European Journal of Medical Physics - Category: Journals (General) Authors: Elette Engels, St éphanie Corde, Sally McKinnon, Sébastien Incerti, Konstantin Konstantinov, Anatoly Rosenfeld, Moeava Tehei, Michael Lerch, Susanna Guatelli Tags: Original paper Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Chemotherapy | General Medicine | Glioma | Nanotechnology | Neurology | Physics | Radiation Therapy